Global and United States Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global and United States Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Drug Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Nexavar (Sorafenib)
1.2.3 Sutent (Sunitinib)
1.2.4 Afinitor (Everolimus)
1.2.5 Votrient (Pazopanib)
1.2.6 Avastin (Bevacizumab)
1.2.7 Inlyta (Axitinib)
1.2.8 Torisel (Temsirolimus)
1.2.9 Proleukin (Aldesleukin)
1.2.10 Other
1.3 Market by Application
1.3.1 Global Kidney Cancer Drug Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Drug Market Perspective (2015-2026)
2.2 Global Kidney Cancer Drug Growth Trends by Regions
2.2.1 Kidney Cancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Kidney Cancer Drug Historic Market Share by Regions (2015-2020)
2.2.3 Kidney Cancer Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Drug Players by Market Size
3.1.1 Global Top Kidney Cancer Drug Players by Revenue (2015-2020)
3.1.2 Global Kidney Cancer Drug Revenue Market Share by Players (2015-2020)
3.2 Global Kidney Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Drug Revenue
3.4 Global Kidney Cancer Drug Market Concentration Ratio
3.4.1 Global Kidney Cancer Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Drug Revenue in 2019
3.5 Key Players Kidney Cancer Drug Area Served
3.6 Key Players Kidney Cancer Drug Product Solution and Service
3.7 Date of Enter into Kidney Cancer Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Drug Breakdown Data by Type (2015-2026)
4.1 Global Kidney Cancer Drug Historic Market Size by Type (2015-2020)
4.2 Global Kidney Cancer Drug Forecasted Market Size by Type (2021-2026)
5 Kidney Cancer Drug Breakdown Data by Application (2015-2026)
5.1 Global Kidney Cancer Drug Historic Market Size by Application (2015-2020)
5.2 Global Kidney Cancer Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Kidney Cancer Drug Market Size (2015-2026)
6.2 North America Kidney Cancer Drug Market Size by Type (2015-2020)
6.3 North America Kidney Cancer Drug Market Size by Application (2015-2020)
6.4 North America Kidney Cancer Drug Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Kidney Cancer Drug Market Size (2015-2026)
7.2 Europe Kidney Cancer Drug Market Size by Type (2015-2020)
7.3 Europe Kidney Cancer Drug Market Size by Application (2015-2020)
7.4 Europe Kidney Cancer Drug Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Kidney Cancer Drug Market Size (2015-2026)
8.2 China Kidney Cancer Drug Market Size by Type (2015-2020)
8.3 China Kidney Cancer Drug Market Size by Application (2015-2020)
8.4 China Kidney Cancer Drug Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Kidney Cancer Drug Market Size (2015-2026)
9.2 Japan Kidney Cancer Drug Market Size by Type (2015-2020)
9.3 Japan Kidney Cancer Drug Market Size by Application (2015-2020)
9.4 Japan Kidney Cancer Drug Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Kidney Cancer Drug Market Size (2015-2026)
10.2 Southeast Asia Kidney Cancer Drug Market Size by Type (2015-2020)
10.3 Southeast Asia Kidney Cancer Drug Market Size by Application (2015-2020)
10.4 Southeast Asia Kidney Cancer Drug Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Active Biotech
11.1.1 Active Biotech Company Details
11.1.2 Active Biotech Business Overview
11.1.3 Active Biotech Kidney Cancer Drug Introduction
11.1.4 Active Biotech Revenue in Kidney Cancer Drug Business (2015-2020))
11.1.5 Active Biotech Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Kidney Cancer Drug Introduction
11.2.4 Amgen Revenue in Kidney Cancer Drug Business (2015-2020)
11.2.5 Amgen Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Kidney Cancer Drug Introduction
11.3.4 Bayer AG Revenue in Kidney Cancer Drug Business (2015-2020)
11.3.5 Bayer AG Recent Development
11.4 Cipla Limited
11.4.1 Cipla Limited Company Details
11.4.2 Cipla Limited Business Overview
11.4.3 Cipla Limited Kidney Cancer Drug Introduction
11.4.4 Cipla Limited Revenue in Kidney Cancer Drug Business (2015-2020)
11.4.5 Cipla Limited Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Kidney Cancer Drug Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2015-2020)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Genentech Business Overview
11.6.3 Genentech Kidney Cancer Drug Introduction
11.6.4 Genentech Revenue in Kidney Cancer Drug Business (2015-2020)
11.6.5 Genentech Recent Development
11.7 Glaxosmithkline PLC
11.7.1 Glaxosmithkline PLC Company Details
11.7.2 Glaxosmithkline PLC Business Overview
11.7.3 Glaxosmithkline PLC Kidney Cancer Drug Introduction
11.7.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2015-2020)
11.7.5 Glaxosmithkline PLC Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Kidney Cancer Drug Introduction
11.8.4 Novartis AG Revenue in Kidney Cancer Drug Business (2015-2020)
11.8.5 Novartis AG Recent Development
11.9 Onyx Pharmaceuticals
11.9.1 Onyx Pharmaceuticals Company Details
11.9.2 Onyx Pharmaceuticals Business Overview
11.9.3 Onyx Pharmaceuticals Kidney Cancer Drug Introduction
11.9.4 Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020)
11.9.5 Onyx Pharmaceuticals Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Kidney Cancer Drug Introduction
11.10.4 Pfizer Revenue in Kidney Cancer Drug Business (2015-2020)
11.10.5 Pfizer Recent Development
11.11 Abbott Laboratories
10.11.1 Abbott Laboratories Company Details
10.11.2 Abbott Laboratories Business Overview
10.11.3 Abbott Laboratories Kidney Cancer Drug Introduction
10.11.4 Abbott Laboratories Revenue in Kidney Cancer Drug Business (2015-2020)
10.11.5 Abbott Laboratories Recent Development
11.12 Aveo Pharmaceuticals
10.12.1 Aveo Pharmaceuticals Company Details
10.12.2 Aveo Pharmaceuticals Business Overview
10.12.3 Aveo Pharmaceuticals Kidney Cancer Drug Introduction
10.12.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020)
10.12.5 Aveo Pharmaceuticals Recent Development
11.13 Immatics Biotechnologies
10.13.1 Immatics Biotechnologies Company Details
10.13.2 Immatics Biotechnologies Business Overview
10.13.3 Immatics Biotechnologies Kidney Cancer Drug Introduction
10.13.4 Immatics Biotechnologies Revenue in Kidney Cancer Drug Business (2015-2020)
10.13.5 Immatics Biotechnologies Recent Development
11.14 Prometheus Laboratories
10.14.1 Prometheus Laboratories Company Details
10.14.2 Prometheus Laboratories Business Overview
10.14.3 Prometheus Laboratories Kidney Cancer Drug Introduction
10.14.4 Prometheus Laboratories Revenue in Kidney Cancer Drug Business (2015-2020)
10.14.5 Prometheus Laboratories Recent Development
11.15 Exelixis
10.15.1 Exelixis Company Details
10.15.2 Exelixis Business Overview
10.15.3 Exelixis Kidney Cancer Drug Introduction
10.15.4 Exelixis Revenue in Kidney Cancer Drug Business (2015-2020)
10.15.5 Exelixis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Kidney Cancer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Nexavar (Sorafenib)
Table 4. Key Players of Sutent (Sunitinib)
Table 5. Key Players of Afinitor (Everolimus)
Table 6. Key Players of Votrient (Pazopanib)
Table 7. Key Players of Avastin (Bevacizumab)
Table 8. Key Players of Inlyta (Axitinib)
Table 9. Key Players of Torisel (Temsirolimus)
Table 10. Key Players of Proleukin (Aldesleukin)
Table 11. Key Players of Other
Table 12. Global Kidney Cancer Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Kidney Cancer Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Kidney Cancer Drug Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Kidney Cancer Drug Market Share by Regions (2015-2020)
Table 16. Global Kidney Cancer Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Kidney Cancer Drug Market Share by Regions (2021-2026)
Table 18. Kidney Cancer Drug Market Market Trends
Table 19. Kidney Cancer Drug Market Drivers
Table 20. Kidney Cancer Drug Market Challenges
Table 21. Kidney Cancer Drug Market Restraints
Table 22. Global Kidney Cancer Drug Revenue by Players (2015-2020) (US$ Million)
Table 23. Global Kidney Cancer Drug Market Share by Players (2015-2020)
Table 24. Global Top Kidney Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drug as of 2019)
Table 25. Global Kidney Cancer Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Kidney Cancer Drug Product Solution and Service
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 30. Global Kidney Cancer Drug Market Size Share by Type (2015-2020)
Table 31. Global Kidney Cancer Drug Revenue Market Share by Type (2021-2026)
Table 32. Global Kidney Cancer Drug Market Size Share by Application (2015-2020)
Table 33. Global Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 34. Global Kidney Cancer Drug Market Size Share by Application (2021-2026)
Table 35. North America Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 36. North America Kidney Cancer Drug Market Share by Type (2015-2020)
Table 37. North America Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 38. North America Kidney Cancer Drug Market Share by Application (2015-2020)
Table 39. North America Kidney Cancer Drug Market Size by Country (US$ Million) (2015-2020)
Table 40. North America Kidney Cancer Drug Market Share by Country (2015-2020)
Table 41. Europe Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 42. Europe Kidney Cancer Drug Market Share by Type (2015-2020)
Table 43. Europe Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 44. Europe Kidney Cancer Drug Market Share by Application (2015-2020)
Table 45. Europe Kidney Cancer Drug Market Size by Country (US$ Million) (2015-2020)
Table 46. Europe Kidney Cancer Drug Market Share by Country (2015-2020)
Table 47. China Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 48. China Kidney Cancer Drug Market Share by Type (2015-2020)
Table 49. China Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 50. China Kidney Cancer Drug Market Share by Application (2015-2020)
Table 51. China Kidney Cancer Drug Market Size by Region (US$ Million) (2015-2020)
Table 52. China Kidney Cancer Drug Market Share by Region (2015-2020)
Table 53. Japan Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 54. Japan Kidney Cancer Drug Market Share by Type (2015-2020)
Table 55. Japan Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 56. Japan Kidney Cancer Drug Market Share by Application (2015-2020)
Table 57. Japan Kidney Cancer Drug Market Size by Country (US$ Million) (2015-2020)
Table 58. Japan Kidney Cancer Drug Market Share by Country (2015-2020)
Table 59. Southeast Asia Kidney Cancer Drug Market Size by Type (2015-2020) (US$ Million)
Table 60. Southeast Asia Kidney Cancer Drug Market Share by Type (2015-2020)
Table 61. Southeast Asia Kidney Cancer Drug Market Size by Application (2015-2020) (US$ Million)
Table 62. Southeast Asia Kidney Cancer Drug Market Share by Application (2015-2020)
Table 63. Southeast Asia Kidney Cancer Drug Market Size by Country (US$ Million) (2015-2020)
Table 64. Southeast Asia Kidney Cancer Drug Market Share by Country (2015-2020)
Table 65. Active Biotech Company Details
Table 66. Active Biotech Business Overview
Table 67. Active Biotech Product
Table 68. Active Biotech Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 69. Active Biotech Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Product
Table 73. Amgen Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 74. Amgen Recent Development
Table 75. Bayer AG Company Details
Table 76. Bayer AG Business Overview
Table 77. Bayer AG Product
Table 78. Bayer AG Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 79. Bayer AG Recent Development
Table 80. Cipla Limited Company Details
Table 81. Cipla Limited Business Overview
Table 82. Cipla Limited Product
Table 83. Cipla Limited Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 84. Cipla Limited Recent Development
Table 85. F. Hoffmann-La Roche Company Details
Table 86. F. Hoffmann-La Roche Business Overview
Table 87. F. Hoffmann-La Roche Product
Table 88. F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 89. F. Hoffmann-La Roche Recent Development
Table 90. Genentech Company Details
Table 91. Genentech Business Overview
Table 92. Genentech Product
Table 93. Genentech Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 94. Genentech Recent Development
Table 95. Glaxosmithkline PLC Company Details
Table 96. Glaxosmithkline PLC Business Overview
Table 97. Glaxosmithkline PLC Product
Table 98. Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 99. Glaxosmithkline PLC Recent Development
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Product
Table 102. Novartis AG Company Details
Table 103. Novartis AG Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 104. Novartis AG Recent Development
Table 105. Onyx Pharmaceuticals Company Details
Table 106. Onyx Pharmaceuticals Business Overview
Table 107. Onyx Pharmaceuticals Product
Table 108. Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 109. Onyx Pharmaceuticals Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 114. Pfizer Recent Development
Table 115. Abbott Laboratories Company Details
Table 116. Abbott Laboratories Business Overview
Table 117. Abbott Laboratories Product
Table 118. Abbott Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 119. Abbott Laboratories Recent Development
Table 120. Aveo Pharmaceuticals Company Details
Table 121. Aveo Pharmaceuticals Business Overview
Table 122. Aveo Pharmaceuticals Product
Table 123. Aveo Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 124. Aveo Pharmaceuticals Recent Development
Table 125. Immatics Biotechnologies Company Details
Table 126. Immatics Biotechnologies Business Overview
Table 127. Immatics Biotechnologies Product
Table 128. Immatics Biotechnologies Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 129. Immatics Biotechnologies Recent Development
Table 130. Prometheus Laboratories Company Details
Table 131. Prometheus Laboratories Business Overview
Table 132. Prometheus Laboratories Product
Table 133. Prometheus Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 134. Prometheus Laboratories Recent Development
Table 135. Exelixis Company Details
Table 136. Exelixis Business Overview
Table 137. Exelixis Product
Table 138. Exelixis Revenue in Kidney Cancer Drug Business (2015-2020) (US$ Million)
Table 139. Exelixis Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Drug Market Share by Type: 2020 VS 2026
Figure 2. Nexavar (Sorafenib) Features
Figure 3. Sutent (Sunitinib) Features
Figure 4. Afinitor (Everolimus) Features
Figure 5. Votrient (Pazopanib) Features
Figure 6. Avastin (Bevacizumab) Features
Figure 7. Inlyta (Axitinib) Features
Figure 8. Torisel (Temsirolimus) Features
Figure 9. Proleukin (Aldesleukin) Features
Figure 10. Other Features
Figure 11. Global Kidney Cancer Drug Market Share by Application: 2020 VS 2026
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Research Center Case Studies
Figure 15. Other Case Studies
Figure 16. Kidney Cancer Drug Report Years Considered
Figure 17. Global Kidney Cancer Drug Market Size (US$ Million), YoY Growth 2015-2026
Figure 18. Global Kidney Cancer Drug Market Share by Regions: 2020 VS 2026
Figure 19. Global Kidney Cancer Drug Market Share by Regions (2021-2026)
Figure 20. Global Kidney Cancer Drug Market Share by Players in 2019
Figure 21. Global Top Kidney Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drug as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Kidney Cancer Drug Revenue in 2019
Figure 23. North America Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. United States Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Canada Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Europe Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Germany Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. France Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. U.K. Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Italy Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Russia Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Nordic Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Europe Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Asia-Pacific Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. China Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Japan Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. South Korea Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Southeast Asia Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. India Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Australia Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Asia-Pacific Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Latin America Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Mexico Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Brazil Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Middle East & Africa Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Turkey Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Saudi Arabia Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. UAE Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Rest of Middle East & Africa Kidney Cancer Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 50. Active Biotech Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 51. Amgen Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 52. Bayer AG Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 53. Cipla Limited Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 55. Genentech Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 56. Glaxosmithkline PLC Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 57. Novartis AG Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 58. Onyx Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 59. Pfizer Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 60. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 61. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 62. Immatics Biotechnologies Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 63. Prometheus Laboratories Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 64. Exelixis Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs